Result of AGM

RNS Number : 5154S
Dr. Martens PLC
14 July 2022
 


14 July 2022

DR. MARTENS PLC

RESULT OF ANNUAL GENERAL MEETING

14 JULY 2022

The Company announces the results of voting at its Annual General Meeting held earlier today and confirms that all resolutions were duly passed on a poll with majorities as set out below.

Resolutions 1 to 15 were proposed as Ordinary Resolutions and resolutions 16 to 19 as Special Resolutions.

Resolution

 

 

 

Votes
For

 

 

%

 

 

Votes Against

 

 

%

 

 

Votes
Total

 

 

Votes Withheld

 

% Voting

Capital Instructed

01

Receive the 2022 Annual Report and Accounts

813,848,188

100.00

0

0.00

813,848,188

783,563

81.36%

02

Approve the Directors' Remuneration Report

807,707,382

99.15

6,923,259

0.85

814,630,641

1,110

81.44%

03

Approve the Final Dividend

811,746,252

99.65

2,885,099

0.35

814,631,351

400

81.44%

04

Re-elect Paul Mason

798,851,082

98.70

10,553,833

1.30

809,404,915

5,226,836

80.92%

05

Re-elect Kenny Wilson

809,826,477

99.41

4,804,764

0.59

814,631,241

510

81.44%

06

Re-elect Jon Mortimore

809,094,165

99.32

5,537,076

0.68

814,631,241

510

81.44%

07

Re-elect Ian Rogers

810,551,309

99.50

4,079,932

0.50

814,631,241

510

81.44%

08

Re-elect Ije Nwokorie

809,887,078

99.42

4,744,163

0.58

814,631,241

510

81.44%

09

Re-elect Lynne Weedall

791,704,376

97.19

22,926,665

2.81

814,631,041

710

81.44%

10

Re-elect Robyn Perriss

803,176,287

98.59

11,454,954

1.41

814,631,241

510

81.44%

11

Re-elect Tara Alhadeff

804,121,618

98.71

10,509,623

1.29

814,631,241

510

81.44%

12

Appoint PricewaterhouseCoopers LLP as auditor

813,775,770

99.89

855,681

0.11

814,631,451

300

81.44%

13

Authorise the Audit & Risk Committee to determine the Auditor's remuneration

814,220,813

99.95

410,638

0.05

814,631,451

300

81.44%

14

Authorise the Company and its subsidiaries to make political donations

809,153,872

99.33

5,476,763

0.67

814,630,635

1,116

81.44%

15

Authorise allotment of shares

797,319,899

97.87

17,311,344

2.13

814,631,243

508

81.44%

16

Authorise general disapplication of pre-emption rights*

813,947,595

99.92

683,756

0.08

814,631,351

400

81.44%

17

Authorise additional disapplication of pre-emption rights*

811,886,184

99.66

2,745,167

0.34

814,631,351

400

81.44%

18

Authorise purchase of own shares*

813,899,052

99.95

446,465

0.05

814,345,517

286,234

81.41%

19

Authorise calling of general meetings on 14 days' notice*

795,268,484

97.62

19,362,867

2.38

814,631,351

400

81.44%

*Special Resolution


The votes of independent shareholders on the resolutions concerning the election or re-election of the Independent Non-Executive Directors are set out below:

Resolution

 

 

Votes
For

 

%

 

Votes Against

 

%

 

Votes
Total

 

Votes Withheld

 

% Independent

Capital Instructed

07

Re-elect Ian Rogers

440,608,869

99.08

4,079,932

0.92

444,688,801

510

70.55%

08

Re-elect Ije Nwokorie

439,944,638

98.93

4,744,163

1.07

444,688,801

510

70.55%

09

Re-elect Lynne Weedall

421,761,936

94.84

22,926,665

5.16

444,688,601

710

70.55%

10

Re-elect Robyn Perriss

433,233,847

97.42

11,454,954

2.58

444,688,801

510

70.55%

 

Notes:

1. Votes "For" and "Against" are expressed as a percentage of votes received.

2. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

3. As at 6.30pm on 12 July 2022 the Company had a total of 1,000,283,652 ordinary shares with voting rights in issue. The total independent voting capital, used to calculate the votes of independent shareholders on resolutions 7-10, was 630,341,212.

4. In accordance with Listing Rule 9.6.2R, copies of the resolutions passed as special business will shortly be available for inspection on the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .  

 

Enquiries

Investors and analysts  

Mark Blythman, Interim Director of Investor Relations                   +44 7570 871207
mark.blythman@drmartens.com

Media                                                    

Gill Hammond, Director of Communications  +44 7384 214248

Maitland                                                    +44 20 7379 5151
Clinton Manning                                       +44 7711 972 662
Joanna Davidson                                      +44 7827 254 567

 

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, "Docs" or "DMs" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. 

 

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGGPUPWMUPPGGC

Companies

Dr. Martens (DOCS)
UK 100

Latest directors dealings